Blood Glucosebeta-GlucansGliclazideHypoglycemic AgentsHyperglycemiaGlucoseHypoglycemiaDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Hemoglobin A, GlycosylatedInsulinDiabetic AngiopathiesIntensive Care UnitsBlood Glucose Self-MonitoringGlucose Tolerance TestIntensive CareGlucose IntoleranceRandomized Controlled Trials as TopicGlucose OxidaseGlucose Transporter Type 1HypertensionGlucose Transporter Type 4Diabetes MellitusFastingMonosaccharide Transport ProteinsIntensive Care Units, PediatricIntensive Care Units, NeonatalDeoxyglucoseGlucagonGlucose 1-DehydrogenaseDiabetes Mellitus, Type 1Blood PressureGlucose Transporter Type 2GluconeogenesisTime FactorsGlycogenIslets of LangerhansPostprandial PeriodRisk FactorsGlucose Transporter Type 3Diagnostic EquipmentObesityLactatesLiverBody WeightLactic AcidGlycosuriaGlucokinaseInsulin Infusion SystemsGlycolysisGlucose DehydrogenasesFatty Acids, NonesterifiedDietary CarbohydratesFructoseGlucose Metabolism DisordersGlucose-6-PhosphateCritical IllnessIntensive Care, NeonatalHomeostasisHexokinaseC-PeptideInsulin-Secreting CellsPhlorhizinBiological TransportMonitoring, PhysiologicBody Mass IndexStreptozocinGlucosephosphatesGlucagon-Like Peptide 1LipidsLiver GlycogenRats, Wistar3-O-MethylglucoseGlucose-6-PhosphataseEnergy MetabolismTriglyceridesHyperinsulinismMethylglucosidesAntihypertensive AgentsMetabolic Syndrome XProspective StudiesMuscle, SkeletalReference ValuesKineticsGlycerolPrevalenceGlycemic IndexCritical CareRats, Sprague-DawleyAdipose TissueDiabetes ComplicationsSodium-Glucose Transporter 1Carbohydrate MetabolismPrediabetic StateTreatment OutcomeCross-Sectional StudiesMonitoring, AmbulatoryCardiovascular DiseasesDose-Response Relationship, DrugEating